Steiner K, Garbe A
Arzneimittelforschung. 1976 Apr;26(4b):709-16.
Distribution of 4,4-diphenyl-N-isopropyl-cyclohexylamine-hydrochloride (pramiverine, Sistalgin) following single and repeated i.v. and p.o. administration, resp., has been studied in rats. After i.v. administration, pramiverine is rapidly taken up by tissue. Most organs attain higher concentrations than does the blood plasma, especially the lungs and also kidneys, liver, heart and endocrine organs. After p.o. administration, a marked first-pass effect of the liver is observed. The metabolites thus formed show a somewhat less pronounced affinity for organs and tissues. Higher concentrations are found only in the excretory organs, i.e. liver and kidneys. 14C-Pramiverine is rapidly eliminated, 24 h after application the level of radioactivity has fallen below detection limit. After repeated applications of 14C-pramiverine higher concentrations, as compared to one single administration, were observed only in liver and kidneys, especially after i.v. injection. An organ-specific accumulation of the drug can be excluded. No placental transfer of pramiverine and/or its metabolites could be observed.
在大鼠中研究了单次及重复静脉注射和口服4,4-二苯基-N-异丙基-环己胺盐酸盐(普拉米维林,西斯塔金)后的分布情况。静脉注射后,普拉米维林迅速被组织摄取。大多数器官中的浓度高于血浆,尤其是肺,还有肾脏、肝脏、心脏和内分泌器官。口服给药后,观察到明显的肝脏首过效应。由此形成的代谢产物对器官和组织的亲和力略低。仅在排泄器官,即肝脏和肾脏中发现较高浓度。14C-普拉米维林迅速消除,给药24小时后放射性水平已降至检测限以下。与单次给药相比,重复应用14C-普拉米维林后,仅在肝脏和肾脏中观察到较高浓度,尤其是静脉注射后。可以排除药物的器官特异性蓄积。未观察到普拉米维林及其代谢产物的胎盘转运。